Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cyclin c'
(id=7013229 ; fe=en:cyclin c ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1414 creation date=2017-06-25 touchdate=2025-05-15 13:36:28.000)
≈ 64 relations sortantes

  1. en:cyclin c -- r_associated #0: 43 / 1 -> en:exposure as collected domain
    n1=en:cyclin c | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=43
  2. en:cyclin c -- r_associated #0: 43 / 1 -> en:historical aspects qualifier
    n1=en:cyclin c | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=43
  3. en:cyclin c -- r_associated #0: 35 / 0.814 -> en:cyclin d
    n1=en:cyclin c | n2=en:cyclin d | rel=r_associated | relid=0 | w=35
  4. en:cyclin c -- r_associated #0: 35 / 0.814 -> en:in urine
    n1=en:cyclin c | n2=en:in urine | rel=r_associated | relid=0 | w=35
  5. en:cyclin c -- r_associated #0: 35 / 0.814 -> en:pharmacokinetic aspects
    n1=en:cyclin c | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=35
  6. en:cyclin c -- r_associated #0: 35 / 0.814 -> en:ultrastructure
    n1=en:cyclin c | n2=en:ultrastructure | rel=r_associated | relid=0 | w=35
  7. en:cyclin c -- r_associated #0: 34 / 0.791 -> cycline c
    n1=en:cyclin c | n2=cycline c | rel=r_associated | relid=0 | w=34
  8. en:cyclin c -- r_associated #0: 34 / 0.791 -> en:aspects of radiation effects
    n1=en:cyclin c | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=34
  9. en:cyclin c -- r_associated #0: 34 / 0.791 -> en:cyclin-c
    n1=en:cyclin c | n2=en:cyclin-c | rel=r_associated | relid=0 | w=34
  10. en:cyclin c -- r_associated #0: 34 / 0.791 -> en:cyclin-h
    n1=en:cyclin c | n2=en:cyclin-h | rel=r_associated | relid=0 | w=34
  11. en:cyclin c -- r_associated #0: 34 / 0.791 -> en:deficiency aspects
    n1=en:cyclin c | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=34
  12. en:cyclin c -- r_associated #0: 32 / 0.744 -> en:cyclin b
    n1=en:cyclin c | n2=en:cyclin b | rel=r_associated | relid=0 | w=32
  13. en:cyclin c -- r_associated #0: 32 / 0.744 -> en:g1/s-specific cyclin-d2
    n1=en:cyclin c | n2=en:g1/s-specific cyclin-d2 | rel=r_associated | relid=0 | w=32
  14. en:cyclin c -- r_associated #0: 32 / 0.744 -> en:g2/mitotic-specific cyclin-b1
    n1=en:cyclin c | n2=en:g2/mitotic-specific cyclin-b1 | rel=r_associated | relid=0 | w=32
  15. en:cyclin c -- r_associated #0: 32 / 0.744 -> en:mechanism of action qualifier
    n1=en:cyclin c | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=32
  16. en:cyclin c -- r_associated #0: 31 / 0.721 -> en:agonists
    n1=en:cyclin c | n2=en:agonists | rel=r_associated | relid=0 | w=31
  17. en:cyclin c -- r_associated #0: 31 / 0.721 -> en:cyclin e
    n1=en:cyclin c | n2=en:cyclin e | rel=r_associated | relid=0 | w=31
  18. en:cyclin c -- r_associated #0: 31 / 0.721 -> en:g1/s-specific cyclin-e1
    n1=en:cyclin c | n2=en:g1/s-specific cyclin-e1 | rel=r_associated | relid=0 | w=31
  19. en:cyclin c -- r_associated #0: 31 / 0.721 -> en:in blood
    n1=en:cyclin c | n2=en:in blood | rel=r_associated | relid=0 | w=31
  20. en:cyclin c -- r_associated #0: 30 / 0.698 -> en:chemical synthesis
    n1=en:cyclin c | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=30
  21. en:cyclin c -- r_associated #0: 30 / 0.698 -> en:cyclin
    n1=en:cyclin c | n2=en:cyclin | rel=r_associated | relid=0 | w=30
  22. en:cyclin c -- r_associated #0: 30 / 0.698 -> en:cyclin g
    n1=en:cyclin c | n2=en:cyclin g | rel=r_associated | relid=0 | w=30
  23. en:cyclin c -- r_associated #0: 30 / 0.698 -> en:cyclin t
    n1=en:cyclin c | n2=en:cyclin t | rel=r_associated | relid=0 | w=30
  24. en:cyclin c -- r_associated #0: 30 / 0.698 -> en:cyclin-a1
    n1=en:cyclin c | n2=en:cyclin-a1 | rel=r_associated | relid=0 | w=30
  25. en:cyclin c -- r_associated #0: 30 / 0.698 -> en:therapeutic use - qualifier
    n1=en:cyclin c | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=30
  26. en:cyclin c -- r_associated #0: 29 / 0.674 -> en:g2/mitotic-specific cyclin-b2
    n1=en:cyclin c | n2=en:g2/mitotic-specific cyclin-b2 | rel=r_associated | relid=0 | w=29
  27. en:cyclin c -- r_associated #0: 29 / 0.674 -> en:mediator complex
    n1=en:cyclin c | n2=en:mediator complex | rel=r_associated | relid=0 | w=29
  28. en:cyclin c -- r_associated #0: 28 / 0.651 -> en:bioformation
    n1=en:cyclin c | n2=en:bioformation | rel=r_associated | relid=0 | w=28
  29. en:cyclin c -- r_associated #0: 28 / 0.651 -> en:ccnc protein, rat
    n1=en:cyclin c | n2=en:ccnc protein, rat | rel=r_associated | relid=0 | w=28
  30. en:cyclin c -- r_associated #0: 28 / 0.651 -> en:cellular secretion
    n1=en:cyclin c | n2=en:cellular secretion | rel=r_associated | relid=0 | w=28
  31. en:cyclin c -- r_associated #0: 28 / 0.651 -> en:cyclin a
    n1=en:cyclin c | n2=en:cyclin a | rel=r_associated | relid=0 | w=28
  32. en:cyclin c -- r_associated #0: 27 / 0.628 -> en:cyclin i
    n1=en:cyclin c | n2=en:cyclin i | rel=r_associated | relid=0 | w=27
  33. en:cyclin c -- r_associated #0: 27 / 0.628 -> en:g1/s-specific cyclin-d3
    n1=en:cyclin c | n2=en:g1/s-specific cyclin-d3 | rel=r_associated | relid=0 | w=27
  34. en:cyclin c -- r_associated #0: 27 / 0.628 -> en:mediator of rna polymerase ii transcription subunit 1
    n1=en:cyclin c | n2=en:mediator of rna polymerase ii transcription subunit 1 | rel=r_associated | relid=0 | w=27
  35. en:cyclin c -- r_associated #0: 26 / 0.605 -> cycline de type c
    n1=en:cyclin c | n2=cycline de type c | rel=r_associated | relid=0 | w=26
  36. en:cyclin c -- r_associated #0: 26 / 0.605 -> en:cyclin-a2
    n1=en:cyclin c | n2=en:cyclin-a2 | rel=r_associated | relid=0 | w=26
  37. en:cyclin c -- r_associated #0: 26 / 0.605 -> en:cyclin-dependent kinase 8
    n1=en:cyclin c | n2=en:cyclin-dependent kinase 8 | rel=r_associated | relid=0 | w=26
  38. en:cyclin c -- r_associated #0: 26 / 0.605 -> en:poisoning aspects
    n1=en:cyclin c | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=26
  39. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:administration & dosage
    n1=en:cyclin c | n2=en:administration & dosage | rel=r_associated | relid=0 | w=25
  40. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:analysis aspect
    n1=en:cyclin c | n2=en:analysis aspect | rel=r_associated | relid=0 | w=25
  41. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:antagonists & inhibitors
    n1=en:cyclin c | n2=en:antagonists & inhibitors | rel=r_associated | relid=0 | w=25
  42. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:aspects of adverse effects
    n1=en:cyclin c | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=25
  43. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:ccnc protein, mouse
    n1=en:cyclin c | n2=en:ccnc protein, mouse | rel=r_associated | relid=0 | w=25
  44. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:ccnd1 gene product
    n1=en:cyclin c | n2=en:ccnd1 gene product | rel=r_associated | relid=0 | w=25
  45. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:chemical aspects
    n1=en:cyclin c | n2=en:chemical aspects | rel=r_associated | relid=0 | w=25
  46. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:contraindications aspect
    n1=en:cyclin c | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=25
  47. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:cycc protein, drosophila
    n1=en:cyclin c | n2=en:cycc protein, drosophila | rel=r_associated | relid=0 | w=25
  48. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:g1/s-specific cyclin-e2
    n1=en:cyclin c | n2=en:g1/s-specific cyclin-e2 | rel=r_associated | relid=0 | w=25
  49. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:genetic aspects
    n1=en:cyclin c | n2=en:genetic aspects | rel=r_associated | relid=0 | w=25
  50. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:in cerebrospinal fluid
    n1=en:cyclin c | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=25
  51. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:isolation & purification analysis
    n1=en:cyclin c | n2=en:isolation & purification analysis | rel=r_associated | relid=0 | w=25
  52. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:mcc1 protein, mycosphaerella graminicola
    n1=en:cyclin c | n2=en:mcc1 protein, mycosphaerella graminicola | rel=r_associated | relid=0 | w=25
  53. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:metabolic aspects
    n1=en:cyclin c | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=25
  54. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:supply & distribution
    n1=en:cyclin c | n2=en:supply & distribution | rel=r_associated | relid=0 | w=25
  55. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:taxonomic
    n1=en:cyclin c | n2=en:taxonomic | rel=r_associated | relid=0 | w=25
  56. en:cyclin c -- r_associated #0: 25 / 0.581 -> en:toxicity aspects
    n1=en:cyclin c | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=25
  57. en:cyclin c -- r_associated #0: 24 / 0.558 -> en:immunology aspects
    n1=en:cyclin c | n2=en:immunology aspects | rel=r_associated | relid=0 | w=24
  58. en:cyclin c -- r_associated #0: 23 / 0.535 -> en:physiological aspects
    n1=en:cyclin c | n2=en:physiological aspects | rel=r_associated | relid=0 | w=23
  59. en:cyclin c -- r_associated #0: 23 / 0.535 -> en:standards characteristics
    n1=en:cyclin c | n2=en:standards characteristics | rel=r_associated | relid=0 | w=23
  60. en:cyclin c -- r_associated #0: 21 / 0.488 -> en:drug effect
    n1=en:cyclin c | n2=en:drug effect | rel=r_associated | relid=0 | w=21
  61. en:cyclin c -- r_associated #0: 20 / 0.465 -> cycline
    n1=en:cyclin c | n2=cycline | rel=r_associated | relid=0 | w=20
  62. en:cyclin c -- r_associated #0: 20 / 0.465 -> effet d'un médicament
    n1=en:cyclin c | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  63. en:cyclin c -- r_associated #0: 20 / 0.465 -> en:ccnc gene
    n1=en:cyclin c | n2=en:ccnc gene | rel=r_associated | relid=0 | w=20
  64. en:cyclin c -- r_associated #0: 2 / 0.047 -> en:amino acid, peptide, or protein
    n1=en:cyclin c | n2=en:amino acid, peptide, or protein | rel=r_associated | relid=0 | w=2
≈ 45 relations entrantes

  1. cycline --- r_associated #0: 75 --> en:cyclin c
    n1=cycline | n2=en:cyclin c | rel=r_associated | relid=0 | w=75
  2. en:cyclin --- r_associated #0: 73 --> en:cyclin c
    n1=en:cyclin | n2=en:cyclin c | rel=r_associated | relid=0 | w=73
  3. effet d'un médicament --- r_associated #0: 47 --> en:cyclin c
    n1=effet d'un médicament | n2=en:cyclin c | rel=r_associated | relid=0 | w=47
  4. en:drug effect --- r_associated #0: 43 --> en:cyclin c
    n1=en:drug effect | n2=en:cyclin c | rel=r_associated | relid=0 | w=43
  5. en:deficiency aspects --- r_associated #0: 39 --> en:cyclin c
    n1=en:deficiency aspects | n2=en:cyclin c | rel=r_associated | relid=0 | w=39
  6. en:bioformation --- r_associated #0: 38 --> en:cyclin c
    n1=en:bioformation | n2=en:cyclin c | rel=r_associated | relid=0 | w=38
  7. en:cyclin-a1 --- r_associated #0: 37 --> en:cyclin c
    n1=en:cyclin-a1 | n2=en:cyclin c | rel=r_associated | relid=0 | w=37
  8. cycline de type c --- r_associated #0: 35 --> en:cyclin c
    n1=cycline de type c | n2=en:cyclin c | rel=r_associated | relid=0 | w=35
  9. en:mechanism of action qualifier --- r_associated #0: 35 --> en:cyclin c
    n1=en:mechanism of action qualifier | n2=en:cyclin c | rel=r_associated | relid=0 | w=35
  10. en:mediator of rna polymerase ii transcription subunit 1 --- r_associated #0: 35 --> en:cyclin c
    n1=en:mediator of rna polymerase ii transcription subunit 1 | n2=en:cyclin c | rel=r_associated | relid=0 | w=35
  11. en:physiological aspects --- r_associated #0: 35 --> en:cyclin c
    n1=en:physiological aspects | n2=en:cyclin c | rel=r_associated | relid=0 | w=35
  12. en:cyclin-dependent kinase 8 --- r_associated #0: 34 --> en:cyclin c
    n1=en:cyclin-dependent kinase 8 | n2=en:cyclin c | rel=r_associated | relid=0 | w=34
  13. en:cyclin-h --- r_associated #0: 34 --> en:cyclin c
    n1=en:cyclin-h | n2=en:cyclin c | rel=r_associated | relid=0 | w=34
  14. en:agonists --- r_associated #0: 32 --> en:cyclin c
    n1=en:agonists | n2=en:cyclin c | rel=r_associated | relid=0 | w=32
  15. en:cyclin t --- r_associated #0: 32 --> en:cyclin c
    n1=en:cyclin t | n2=en:cyclin c | rel=r_associated | relid=0 | w=32
  16. en:exposure as collected domain --- r_associated #0: 32 --> en:cyclin c
    n1=en:exposure as collected domain | n2=en:cyclin c | rel=r_associated | relid=0 | w=32
  17. en:immunology aspects --- r_associated #0: 32 --> en:cyclin c
    n1=en:immunology aspects | n2=en:cyclin c | rel=r_associated | relid=0 | w=32
  18. en:ccnc gene --- r_associated #0: 31 --> en:cyclin c
    n1=en:ccnc gene | n2=en:cyclin c | rel=r_associated | relid=0 | w=31
  19. en:cyclin g --- r_associated #0: 31 --> en:cyclin c
    n1=en:cyclin g | n2=en:cyclin c | rel=r_associated | relid=0 | w=31
  20. en:cyclin i --- r_associated #0: 31 --> en:cyclin c
    n1=en:cyclin i | n2=en:cyclin c | rel=r_associated | relid=0 | w=31
  21. en:cyclin-a2 --- r_associated #0: 31 --> en:cyclin c
    n1=en:cyclin-a2 | n2=en:cyclin c | rel=r_associated | relid=0 | w=31
  22. en:g1/s-specific cyclin-d3 --- r_associated #0: 31 --> en:cyclin c
    n1=en:g1/s-specific cyclin-d3 | n2=en:cyclin c | rel=r_associated | relid=0 | w=31
  23. cycline c --- r_associated #0: 30 --> en:cyclin c
    n1=cycline c | n2=en:cyclin c | rel=r_associated | relid=0 | w=30
  24. en:therapeutic use - qualifier --- r_associated #0: 28 --> en:cyclin c
    n1=en:therapeutic use - qualifier | n2=en:cyclin c | rel=r_associated | relid=0 | w=28
  25. en:g2/mitotic-specific cyclin-b2 --- r_associated #0: 26 --> en:cyclin c
    n1=en:g2/mitotic-specific cyclin-b2 | n2=en:cyclin c | rel=r_associated | relid=0 | w=26
  26. en:pharmacokinetic aspects --- r_associated #0: 26 --> en:cyclin c
    n1=en:pharmacokinetic aspects | n2=en:cyclin c | rel=r_associated | relid=0 | w=26
  27. en:standards characteristics --- r_associated #0: 26 --> en:cyclin c
    n1=en:standards characteristics | n2=en:cyclin c | rel=r_associated | relid=0 | w=26
  28. en:ccnc protein, rat --- r_associated #0: 21 --> en:cyclin c
    n1=en:ccnc protein, rat | n2=en:cyclin c | rel=r_associated | relid=0 | w=21
  29. en:aspects of radiation effects --- r_associated #0: 20 --> en:cyclin c
    n1=en:aspects of radiation effects | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  30. en:cellular secretion --- r_associated #0: 20 --> en:cyclin c
    n1=en:cellular secretion | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  31. en:chemical synthesis --- r_associated #0: 20 --> en:cyclin c
    n1=en:chemical synthesis | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  32. en:cyclin a --- r_associated #0: 20 --> en:cyclin c
    n1=en:cyclin a | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  33. en:cyclin b --- r_associated #0: 20 --> en:cyclin c
    n1=en:cyclin b | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  34. en:cyclin d --- r_associated #0: 20 --> en:cyclin c
    n1=en:cyclin d | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  35. en:cyclin e --- r_associated #0: 20 --> en:cyclin c
    n1=en:cyclin e | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  36. en:cyclin-c --- r_associated #0: 20 --> en:cyclin c
    n1=en:cyclin-c | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  37. en:g1/s-specific cyclin-d2 --- r_associated #0: 20 --> en:cyclin c
    n1=en:g1/s-specific cyclin-d2 | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  38. en:g1/s-specific cyclin-e1 --- r_associated #0: 20 --> en:cyclin c
    n1=en:g1/s-specific cyclin-e1 | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  39. en:g2/mitotic-specific cyclin-b1 --- r_associated #0: 20 --> en:cyclin c
    n1=en:g2/mitotic-specific cyclin-b1 | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  40. en:historical aspects qualifier --- r_associated #0: 20 --> en:cyclin c
    n1=en:historical aspects qualifier | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  41. en:in blood --- r_associated #0: 20 --> en:cyclin c
    n1=en:in blood | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  42. en:in urine --- r_associated #0: 20 --> en:cyclin c
    n1=en:in urine | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  43. en:mediator complex --- r_associated #0: 20 --> en:cyclin c
    n1=en:mediator complex | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  44. en:poisoning aspects --- r_associated #0: 20 --> en:cyclin c
    n1=en:poisoning aspects | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
  45. en:ultrastructure --- r_associated #0: 20 --> en:cyclin c
    n1=en:ultrastructure | n2=en:cyclin c | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr